I

Integrum AB
STO:INTEG B

Watchlist Manager
Integrum AB
STO:INTEG B
Watchlist
Price: 9.76 SEK -1.31% Market Closed
Market Cap: kr254.1m

Relative Value

The Relative Value of one INTEG B stock under the Base Case scenario is hidden SEK. Compared to the current market price of 9.76 SEK, Integrum AB is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

INTEG B Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

INTEG B Competitors Multiples
Integrum AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Integrum AB
STO:INTEG B
254.1m SEK 2.6 -8.5 -5.5 -5.5
US
Abbott Laboratories
NYSE:ABT
188.5B USD 4.3 28.9 16.4 22.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
173.6B USD 17.1 60.2 45.9 55.6
US
Stryker Corp
NYSE:SYK
138.1B USD 5.5 42.5 21.6 26.1
US
Boston Scientific Corp
NYSE:BSX
135.7B USD 7 48.6 28.5 38.7
IE
Medtronic PLC
NYSE:MDT
134.2B USD 3.8 27.9 15.6 22.6
US
Becton Dickinson and Co
NYSE:BDX
58.9B USD 2.7 35.1 12.8 21.9
DE
Siemens Healthineers AG
XETRA:SHL
47.1B EUR 2 22.1 12.5 17.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
50.8B USD 12.2 49.4 35.5 39.3
US
Edwards Lifesciences Corp
NYSE:EW
47.9B USD 8.1 35 24.9 27.3
US
Resmed Inc
NYSE:RMD
37B USD 6.8 24.7 17.4 19.4
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
I
Integrum AB
STO:INTEG B
Average EV/EBITDA: 23.1
Negative Multiple: -5.5
N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.4
9%
1.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
45.9
24%
1.9
US
Stryker Corp
NYSE:SYK
21.6
12%
1.8
US
Boston Scientific Corp
NYSE:BSX
28.5
22%
1.3
IE
Medtronic PLC
NYSE:MDT
15.6
8%
2
US
Becton Dickinson and Co
NYSE:BDX
12.8
8%
1.6
DE
Siemens Healthineers AG
XETRA:SHL
12.5
11%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
35.5
14%
2.5
US
Edwards Lifesciences Corp
NYSE:EW
24.9
13%
1.9
US
Resmed Inc
NYSE:RMD
17.4
11%
1.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
I
Integrum AB
STO:INTEG B
Average EV/EBIT: 29.1
Negative Multiple: -5.5
N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.4
17%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
55.6
25%
2.2
US
Stryker Corp
NYSE:SYK
26.1
16%
1.6
US
Boston Scientific Corp
NYSE:BSX
38.7
32%
1.2
IE
Medtronic PLC
NYSE:MDT
22.6
17%
1.3
US
Becton Dickinson and Co
NYSE:BDX
21.9
21%
1
DE
Siemens Healthineers AG
XETRA:SHL
17.6
15%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.3
15%
2.6
US
Edwards Lifesciences Corp
NYSE:EW
27.3
14%
2
US
Resmed Inc
NYSE:RMD
19.4
12%
1.6